60 Degrees Pharmaceuticals (SXTP) Return on Assets (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Return on Assets of 0.01% for Q1 2026, little changed year-over-year from 0.01% in Q1 2025, and down 2.45% quarter-over-quarter from 0.01% in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Return on Assets (2023 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Return on Assets for 4 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets retreated to 0.01% in Q1 2026 per SXTP's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2024 and bottomed at 0.01% in Q1 2025.
- Historically, Return on Assets has averaged 0.01% across 4 years, with a median of 0.01% in 2025.
- Annual changes were most pronounced in 2024 — Return on Assets decreased 1 bps — and 2025, when it changed 0 bps.
- 60 Degrees Pharmaceuticals' Return on Assets stood at 0.0% in 2023, then tumbled by 112 bps to 0.01% in 2024, then declined by 20 bps to 0.01% in 2025, then slipped by 2 bps to 0.01% in 2026.
- Business Quant data shows SXTP's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 0.00% |
| 10 | 60 Degrees Pharmaceuticals | 3.03 Mn | 2.00 Mn | 56,798.00 | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |